Product image of Ondansetron Eg (Ondansetron Hydrochloride Dihydrate) supplied by GNH India

Ondansetron Eg

Active Ingredient:
Ondansetron Hydrochloride Dihydrate
Origin:
EU

Ondansetron Eg (Ondansetron Hydrochloride Dihydrate)

Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Eg, is a serotonin 5-HT3 receptor antagonist presented as an oral dosage form for oral use. It prevents nausea and vomiting associated with chemotherapy, postoperative recovery, and radiotherapy in adult patients.

GNH India supplies Ondansetron Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eurogenerics N.V./S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron Eg is a selective 5‑HT3 receptor antagonist used to control nausea and vomiting in several clinical settings.

  • Chemotherapy‑induced nausea and vomiting: prevents or reduces nausea and vomiting caused by cancer chemotherapy.
  • Postoperative nausea and vomiting: reduces the incidence of nausea and vomiting after surgical procedures.
  • Radiotherapy‑induced nausea and vomiting: helps control nausea and vomiting associated with radiation treatment.

How It Works

  • Ondansetron acts as a selective antagonist of serotonin (5‑HT3) receptors located in the chemoreceptor trigger zone of the brain and in the gastrointestinal tract. By blocking these receptors, it inhibits serotonin‑mediated signaling that triggers the vomiting reflex, thereby reducing nausea and vomiting.

Side Effects

Ondansetron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Headache: mild to moderate pain in the head.
  • Constipation: reduced bowel movements or hard stools.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Fatigue: feeling unusually tired or weak.

Serious or Rare Side Effects

  • QT prolongation: potential heart rhythm disturbance that may lead to arrhythmia.
  • Severe allergic reaction (anaphylaxis): rapid onset of swelling, rash, and breathing difficulty.
  • Serotonin syndrome: rare condition with agitation, hyperthermia, and muscle rigidity.

Precautions & Warnings

Before prescribing Ondansetron Eg, clinicians should consider several safety aspects.

  • Cardiac assessment: evaluate history of arrhythmias or prolonged QT interval.
  • Electrolyte monitoring: correct hypokalemia, hypomagnesemia, or hypocalcemia which can exacerbate QT prolongation.
  • Hepatic impairment: use with caution in patients with liver dysfunction.
  • Concomitant QT‑prolonging drugs: avoid or monitor closely when combined with other agents that affect cardiac repolarization.
  • Dose adjustment: consider renal or hepatic function when determining dose.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Ondansetron Eg can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Apomorphine: co‑administration may cause severe hypotension and loss of consciousness.
  • Other 5‑HT3 antagonists: concurrent use provides no added benefit and may increase toxicity.
  • QT‑prolonging agents (e.g., quinidine, amiodarone): may significantly increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

  • Anticholinergics: may reduce the anti‑emetic efficacy of ondansetron.
  • Corticosteroids: can enhance the anti‑emetic effect, requiring dose review.
  • CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may raise ondansetron plasma levels.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine): may lower ondansetron concentrations and reduce effectiveness.

Frequently Asked Questions

Ondansetron Eg is an oral anti‑emetic medication used to prevent and treat nausea and vomiting that can occur after chemotherapy, surgery, or radiotherapy. It works by blocking serotonin receptors that trigger the vomiting reflex, helping patients maintain comfort and continue their treatment regimens.

Ondansetron selectively blocks serotonin (5‑HT3) receptors in the chemoreceptor trigger zone of the brain and in the gastrointestinal tract. By preventing serotonin from binding to these receptors, it interrupts the signaling pathway that initiates nausea and vomiting, thereby providing relief.

The specific dose of Ondansetron Eg is determined by the prescribing clinician based on the patient’s condition, age, weight, and treatment protocol. Healthcare professionals adjust the regimen to achieve optimal anti‑emetic control while minimizing potential side effects.

Safety data for ondansetron in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider after evaluating the individual situation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Ondansetron Eg. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ondansetron belongs to the 5‑HT3 antagonist class, which is generally more effective for chemotherapy‑induced nausea than older agents such as dopamine antagonists (e.g., metoclopramide). It has a favorable side‑effect profile but may require caution in patients with cardiac risk factors, whereas some alternatives may cause more sedation or extrapyramidal symptoms.

Ondansetron Eg should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Ondansetron Eg is taken orally, usually as a tablet, with or without food as directed by the prescriber. The medication should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

The most serious risks include cardiac arrhythmias such as QT interval prolongation, which can lead to torsades de pointes, and severe allergic reactions like anaphylaxis. Patients should be monitored for any signs of heart rhythm changes or hypersensitivity, especially when taking other QT‑prolonging drugs.

Ondansetron should be avoided in patients with known hypersensitivity to the drug or any of its components. It is also contraindicated in individuals taking apomorphine due to risk of severe hypotension, and should be used with caution in patients with significant cardiac conduction abnormalities or electrolyte imbalances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron Hydrochloride Dihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT